Download PDF
Semin Neurol 2019; 39(02): 251-263
DOI: 10.1055/s-0039-1683379
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Frontotemporal Dementia: A Clinical Review

Harri Sivasathiaseelan
1   Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom
,
Charles R. Marshall
1   Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom
2   Preventive Neurology Unit, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom
,
Jennifer L. Agustus
1   Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom
,
Elia Benhamou
1   Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom
,
Rebecca L. Bond
1   Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom
,
Janneke E. P. van Leeuwen
1   Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom
,
Chris J. D. Hardy
1   Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom
,
Jonathan D. Rohrer
1   Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom
,
Jason D. Warren
1   Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom
› Author Affiliations
Further Information

Publication History

Publication Date:
29 March 2019 (online)

    Permissions and Reprints

Abstract

Frontotemporal dementias are a clinically, neuroanatomically, and pathologically diverse group of diseases that collectively constitute an important cause of young-onset dementia. Clinically, frontotemporal dementias characteristically strike capacities that define us as individuals, presenting broadly as disorders of social behavior or language. Neurobiologically, these diseases can be regarded as “molecular nexopathies,” a paradigm for selective targeting and destruction of brain networks by pathogenic proteins. Mutations in three major genes collectively account for a substantial proportion of behavioral presentations, with far-reaching implications for the lives of families but also potential opportunities for presymptomatic diagnosis and intervention. Predicting molecular pathology from clinical and radiological phenotypes remains challenging; however, certain patterns have been identified, and genetically mediated forms of frontotemporal dementia have spearheaded this enterprise. Here we present a clinical roadmap for diagnosis and assessment of the frontotemporal dementias, motivated by our emerging understanding of the mechanisms by which pathogenic protein effects at the cellular level translate to abnormal neural network physiology and ultimately, complex clinical symptoms. We conclude by outlining principles of management and prospects for disease modification.

Keywords

frontotemporal dementia - primary progressive aphasia - behavioral variant FTD - semantic dementia
 

  • References

  • 1 Warren JD, Rohrer JD, Rossor MN. Clinical review. Frontotemporal dementia. BMJ 2013; 347: f4827
    CrossrefPubMedGoogle Scholar
  • 2 Woollacott IO, Rohrer JD. The clinical spectrum of sporadic and familial forms of frontotemporal dementia. J Neurochem 2016; 138 (Suppl. 01) 6-31
    CrossrefPubMedGoogle Scholar
  • 3 Marshall CR, Hardy CJD, Volkmer A. , et al. Primary progressive aphasia: a clinical approach. J Neurol 2018; 265 (06) 1474-1490
    CrossrefPubMedGoogle Scholar
  • 4 Pick A. Über die Beziehungen der senilen Hirnatrophie zur Aphasie. Prag Med Wochenschr 1892; 17: 165-167
    PubMedGoogle Scholar
  • 5 Pick A. Über primare progressive Demenz bei Erwachsenen. Prag Med Wochenschr 1904; 29: 417-420
    PubMedGoogle Scholar
  • 6 Warrington EK. The selective impairment of semantic memory. Q J Exp Psychol 1975; 27 (04) 635-657
    CrossrefPubMedGoogle Scholar
  • 7 Mesulam MM. Slowly progressive aphasia without generalized dementia. Ann Neurol 1982; 11 (06) 592-598
    CrossrefPubMedGoogle Scholar
  • 8 Gustafson L. Frontal lobe degeneration of non-Alzheimer type. II. Clinical picture and differential diagnosis. Arch Gerontol Geriatr 1987; 6 (03) 209-223
    CrossrefPubMedGoogle Scholar
  • 9 Neary D, Snowden JS, Northen B, Goulding P. Dementia of frontal lobe type. J Neurol Neurosurg Psychiatry 1988; 51 (03) 353-361
    CrossrefPubMedGoogle Scholar
  • 10 Brun A, Englund B, Gustafson L. , et al; The Lund and Manchester Groups. Clinical and neuropathological criteria for frontotemporal dementia. J Neurol Neurosurg Psychiatry 1994; 57 (04) 416-418
    CrossrefPubMedGoogle Scholar
  • 11 Hutton M, Lendon CL, Rizzu P. , et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998; 393 (6686): 702-705
    CrossrefPubMedGoogle Scholar
  • 12 Rascovsky K, Hodges JR, Knopman D. , et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 2011; 134 (Pt 9): 2456-2477
    CrossrefPubMedGoogle Scholar
  • 13 Gorno-Tempini ML, Hillis AE, Weintraub S. , et al. Classification of primary progressive aphasia and its variants. Neurology 2011; 76 (11) 1006-1014
    CrossrefPubMedGoogle Scholar
  • 14 Seeley WW, Crawford RK, Zhou J, Miller BL, Greicius MD. Neurodegenerative diseases target large-scale human brain networks. Neuron 2009; 62 (01) 42-52
    CrossrefPubMedGoogle Scholar
  • 15 Rohrer JD, Warren JD. Phenotypic signatures of genetic frontotemporal dementia. Curr Opin Neurol 2011; 24 (06) 542-549
    CrossrefPubMedGoogle Scholar
  • 16 Rohrer JD, Lashley T, Schott JM. , et al. Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration. Brain 2011; 134 (Pt 9): 2565-2581
    CrossrefPubMedGoogle Scholar
  • 17 Mackenzie IR, Neumann M, Baborie A. , et al. A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol 2011; 122 (01) 111-113
    CrossrefPubMedGoogle Scholar
  • 18 Rohrer JD, Nicholas JM, Cash DM. , et al. Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysis. Lancet Neurol 2015; 14 (03) 253-262
    CrossrefPubMedGoogle Scholar
  • 19 Coyle-Gilchrist IT, Dick KM, Patterson K. , et al. Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromes. Neurology 2016; 86 (18) 1736-1743
    CrossrefPubMedGoogle Scholar
  • 20 Snowden JS, Thompson JC, Stopford CL. , et al. The clinical diagnosis of early-onset dementias: diagnostic accuracy and clinicopathological relationships. Brain 2011; 134 (Pt 9): 2478-2492
    CrossrefPubMedGoogle Scholar
  • 21 Mesulam MM. Primary progressive aphasia and the language network: the 2013 H. Houston Merritt Lecture. Neurology 2013; 81 (05) 456-462
    CrossrefPubMedGoogle Scholar
  • 22 Nicholson AM, Rademakers R. What we know about TMEM106B in neurodegeneration. Acta Neuropathol 2016; 132 (05) 639-651
    CrossrefPubMedGoogle Scholar
  • 23 Mackenzie IR, Neumann M. Molecular neuropathology of frontotemporal dementia: insights into disease mechanisms from postmortem studies. J Neurochem 2016; 138 (Suppl. 01) 54-70
    CrossrefPubMedGoogle Scholar
  • 24 Rohrer JD, Guerreiro R, Vandrovcova J. , et al. The heritability and genetics of frontotemporal lobar degeneration. Neurology 2009; 73 (18) 1451-1456
    CrossrefPubMedGoogle Scholar
  • 25 Rohrer JD, Warren JD. Phenomenology and anatomy of abnormal behaviours in primary progressive aphasia. J Neurol Sci 2010; 293 (1–2): 35-38
    CrossrefPubMedGoogle Scholar
  • 26 Piguet O, Hodges JR. Behavioural-variant frontotemporal dementia: an update. Dement Neuropsychol 2013; 7 (01) 10-18
    CrossrefPubMedGoogle Scholar
  • 27 Pottier C, Ravenscroft TA, Sanchez-Contreras M, Rademakers R. Genetics of FTLD: overview and what else we can expect from genetic studies. J Neurochem 2016; 138 (Suppl. 01) 32-53
    CrossrefPubMedGoogle Scholar
  • 28 Rademakers R, Neumann M, Mackenzie IR. Advances in understanding the molecular basis of frontotemporal dementia. Nat Rev Neurol 2012; 8 (08) 423-434
    CrossrefPubMedGoogle Scholar
  • 29 Pickering-Brown SM, Rollinson S, Du Plessis D. , et al. Frequency and clinical characteristics of progranulin mutation carriers in the Manchester frontotemporal lobar degeneration cohort: comparison with patients with MAPT and no known mutations. Brain 2008; 131 (Pt 3): 721-731
    CrossrefPubMedGoogle Scholar
  • 30 Seelaar H, Kamphorst W, Rosso SM. , et al. Distinct genetic forms of frontotemporal dementia. Neurology 2008; 71 (16) 1220-1226
    CrossrefPubMedGoogle Scholar
  • 31 Bang J, Spina S, Miller BL. Frontotemporal dementia. Lancet 2015; 386 (10004): 1672-1682
    CrossrefPubMedGoogle Scholar
  • 32 Gijselinck I, Van Mossevelde S, van der Zee J. , et al; BELNEU Consortium. Loss of TBK1 is a frequent cause of frontotemporal dementia in a Belgian cohort. Neurology 2015; 85 (24) 2116-2125
    CrossrefPubMedGoogle Scholar
  • 33 Mishra A, Ferrari R, Heutink P, Hardy J, Pijnenburg Y, Posthuma D. ; International FTD-Genomics Consortium. Gene-based association studies report genetic links for clinical subtypes of frontotemporal dementia. Brain 2017; 140 (05) 1437-1446
    CrossrefPubMedGoogle Scholar
  • 34 Taskesen E, Mishra A, van der Sluis S. , et al; International FTD-Genomics Consortium. Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS. Sci Rep 2017; 7 (01) 8899
    CrossrefPubMedGoogle Scholar
  • 35 Warren JD, Rohrer JD, Schott JM, Fox NC, Hardy J, Rossor MN. Molecular nexopathies: a new paradigm of neurodegenerative disease. Trends Neurosci 2013; 36 (10) 561-569
    CrossrefPubMedGoogle Scholar
  • 36 Mahoney CJ, Beck J, Rohrer JD. , et al. Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features. Brain 2012; 135 (Pt 3): 736-750
    CrossrefPubMedGoogle Scholar
  • 37 Whitwell JL, Josephs KA. Neuroimaging in frontotemporal lobar degeneration--predicting molecular pathology. Nat Rev Neurol 2012; 8 (03) 131-142
    CrossrefPubMedGoogle Scholar
  • 38 Georgiadis K, Wray S, Ourselin S, Warren JD, Modat M. Computational modelling of pathogenic protein spread in neurodegenerative diseases. PLoS One 2018; 13 (02) e0192518
    CrossrefPubMedGoogle Scholar
  • 39 Sami S, Williams N, Hughes LE. , et al. Neurophysiological signatures of Alzheimer's disease and frontotemporal lobar degeneration: pathology versus phenotype. Brain 2018; 141 (08) 2500-2510
    CrossrefPubMedGoogle Scholar
  • 40 Sommerlad A, Lee J, Warren J, Price G. Neurodegenerative disorder masquerading as psychosis in a forensic psychiatry setting. BMJ Case Rep 2014; 2014: 2014
    CrossrefPubMedGoogle Scholar
  • 41 Ramanan S, Bertoux M, Flanagan E. , et al. Longitudinal executive function and episodic memory profiles in behavioral-variant frontotemporal dementia and Alzheimer's disease. J Int Neuropsychol Soc 2017; 23 (01) 34-43
    CrossrefPubMedGoogle Scholar
  • 42 Beck J, Rohrer JD, Campbell T. , et al. A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series. Brain 2008; 131 (Pt 3): 706-720
    CrossrefPubMedGoogle Scholar
  • 43 Devenney E, Swinn T, Mioshi E. , et al. The behavioural variant frontotemporal dementia phenocopy syndrome is a distinct entity - evidence from a longitudinal study. BMC Neurol 2018; 18 (01) 56
    CrossrefPubMedGoogle Scholar
  • 44 Clark CN, Nicholas JM, Gordon E. , et al. Altered sense of humor in dementia. J Alzheimers Dis 2016; 49 (01) 111-119
    PubMedGoogle Scholar
  • 45 Ahmed RM, Goldberg ZL, Kaizik C. , et al. Neural correlates of changes in sexual function in frontotemporal dementia: implications for reward and physiological functioning. J Neurol 2018; 265 (11) 2562-2572
    CrossrefPubMedGoogle Scholar
  • 46 Fletcher PD, Downey LE, Golden HL. , et al. Auditory hedonic phenotypes in dementia: a behavioural and neuroanatomical analysis. Cortex 2015; 67: 95-105
    CrossrefPubMedGoogle Scholar
  • 47 Fletcher PD, Downey LE, Golden HL. , et al. Pain and temperature processing in dementia: a clinical and neuroanatomical analysis. Brain 2015; 138 (Pt 11): 3360-3372
    CrossrefPubMedGoogle Scholar
  • 48 Erkkinen MG, Zúñiga RG, Pardo CC, Miller BL, Miller ZA. Artistic renaissance in frontotemporal dementia. JAMA 2018; 319 (13) 1304-1306
    CrossrefPubMedGoogle Scholar
  • 49 Devenney EM, Landin-Romero R, Irish M. , et al. The neural correlates and clinical characteristics of psychosis in the frontotemporal dementia continuum and the C9orf72 expansion. Neuroimage Clin 2016; 13: 439-445
    PubMedGoogle Scholar
  • 50 Hardy CJ, Buckley AH, Downey LE. , et al. The language profile of behavioral variant frontotemporal dementia. J Alzheimers Dis 2016; 50 (02) 359-371
    PubMedGoogle Scholar
  • 51 Whitwell JL, Przybelski SA, Weigand SD. , et al. Distinct anatomical subtypes of the behavioural variant of frontotemporal dementia: a cluster analysis study. Brain 2009; 132 (Pt 11): 2932-2946
    CrossrefPubMedGoogle Scholar
  • 52 Chan D, Anderson V, Pijnenburg Y. , et al. The clinical profile of right temporal lobe atrophy. Brain 2009; 132 (Pt 5): 1287-1298
    CrossrefPubMedGoogle Scholar
  • 53 Marshall CR, Hardy CJD, Russell LL. , et al. Motor signatures of emotional reactivity in frontotemporal dementia. Sci Rep 2018; 8 (01) 1030
    CrossrefPubMedGoogle Scholar
  • 54 Mahoney CJ, Rohrer JD, Goll JC, Fox NC, Rossor MN, Warren JD. Structural neuroanatomy of tinnitus and hyperacusis in semantic dementia. J Neurol Neurosurg Psychiatry 2011; 82 (11) 1274-1278
    CrossrefPubMedGoogle Scholar
  • 55 Marshall CR, Hardy CJD, Russell LL. , et al. Impaired interoceptive accuracy in semantic variant primary progressive aphasia. Front Neurol 2017; 8: 610
    CrossrefPubMedGoogle Scholar
  • 56 Irish M, Addis DR, Hodges JR, Piguet O. Considering the role of semantic memory in episodic future thinking: evidence from semantic dementia. Brain 2012; 135 (Pt 7): 2178-2191
    CrossrefPubMedGoogle Scholar
  • 57 Sabodash V, Mendez MF, Fong S, Hsiao JJ. Suicidal behavior in dementia: a special risk in semantic dementia. Am J Alzheimers Dis Other Demen 2013; 28 (06) 592-599
    CrossrefPubMedGoogle Scholar
  • 58 Kremen SA, Mendez MF, Tsai P-H, Teng E. Extrapyramidal signs in the primary progressive aphasias. Am J Alzheimers Dis Other Demen 2011; 26 (01) 72-77
    CrossrefPubMedGoogle Scholar
  • 59 Josephs KA, Whitwell JL, Murray ME. , et al. Corticospinal tract degeneration associated with TDP-43 type C pathology and semantic dementia. Brain 2013; 136 (Pt 2): 455-470
    CrossrefPubMedGoogle Scholar
  • 60 Warren JD, Hardy CJ, Fletcher PD. , et al. Binary reversals in primary progressive aphasia. Cortex 2016; 82: 287-289
    CrossrefPubMedGoogle Scholar
  • 61 Josephs KA, Duffy JR, Strand EA. , et al. Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. Brain 2006; 129 (Pt 6): 1385-1398
    CrossrefPubMedGoogle Scholar
  • 62 Rohrer JD, Rossor MN, Warren JD. Syndromes of nonfluent primary progressive aphasia: a clinical and neurolinguistic analysis. Neurology 2010; 75 (07) 603-610
    CrossrefPubMedGoogle Scholar
  • 63 Hardy CJ, Marshall CR, Golden HL. , et al. Hearing and dementia. J Neurol 2016; 263 (11) 2339-2354
    CrossrefPubMedGoogle Scholar
  • 64 Rohrer JD, Rossor MN, Warren JD. Apraxia in progressive nonfluent aphasia. J Neurol 2010; 257 (04) 569-574
    CrossrefPubMedGoogle Scholar
  • 65 Warren JD, Warren JE, Fox NC, Warrington EK. Nothing to say, something to sing: primary progressive dynamic aphasia. Neurocase 2003; 9 (02) 140-155
    CrossrefPubMedGoogle Scholar
  • 66 Magdalinou NK, Golden HL, Nicholas JM. , et al. Verbal adynamia in parkinsonian syndromes: behavioral correlates and neuroanatomical substrate. Neurocase 2018; 24 (04) 204-212
    CrossrefPubMedGoogle Scholar
  • 67 Rohrer JD, Paviour D, Bronstein AM, O'Sullivan SS, Lees A, Warren JD. Progressive supranuclear palsy syndrome presenting as progressive nonfluent aphasia: a neuropsychological and neuroimaging analysis. Mov Disord 2010; 25 (02) 179-188
    CrossrefPubMedGoogle Scholar
  • 68 Rohrer JD, Crutch SJ, Warrington EK, Warren JD. Progranulin-associated primary progressive aphasia: a distinct phenotype?. Neuropsychologia 2010; 48 (01) 288-297
    CrossrefPubMedGoogle Scholar
  • 69 Rossor MN, Fox NC, Mummery CJ, Schott JM, Warren JD. The diagnosis of young-onset dementia. Lancet Neurol 2010; 9 (08) 793-806
    CrossrefPubMedGoogle Scholar
  • 70 Ahmed RM, Murphy E, Davagnanam I. , et al. A practical approach to diagnosing adult onset leukodystrophies. J Neurol Neurosurg Psychiatry 2014; 85 (07) 770-781
    CrossrefPubMedGoogle Scholar
  • 71 Ossenkoppele R, Pijnenburg YA, Perry DC. , et al. The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features. Brain 2015; 138 (Pt 9): 2732-2749
    CrossrefPubMedGoogle Scholar
  • 72 Brodaty H, Seeher K, Gibson L. Dementia time to death: a systematic literature review on survival time and years of life lost in people with dementia. Int Psychogeriatr 2012; 24 (07) 1034-1045
    CrossrefPubMedGoogle Scholar
  • 73 Kertesz A, McMonagle P, Blair M, Davidson W, Munoz DG. The evolution and pathology of frontotemporal dementia. Brain 2005; 128 (Pt 9): 1996-2005
    CrossrefPubMedGoogle Scholar
  • 74 Mendez MF, Shapira JS, McMurtray A, Licht E. Preliminary findings: behavioral worsening on donepezil in patients with frontotemporal dementia. Am J Geriatr Psychiatry 2007; 15 (01) 84-87
    CrossrefPubMedGoogle Scholar
  • 75 Vercelletto M, Boutoleau-Bretonnière C, Volteau C. , et al; French research network on Frontotemporal dementia. Memantine in behavioral variant frontotemporal dementia: negative results. J Alzheimers Dis 2011; 23 (04) 749-759
    CrossrefPubMedGoogle Scholar
  • 76 Swartz JR, Miller BL, Lesser IM, Darby AL. Frontotemporal dementia: treatment response to serotonin selective reuptake inhibitors. J Clin Psychiatry 1997; 58 (05) 212-216
    CrossrefPubMedGoogle Scholar
  • 77 Deakin JB, Rahman S, Nestor PJ, Hodges JR, Sahakian BJ. Paroxetine does not improve symptoms and impairs cognition in frontotemporal dementia: a double-blind randomized controlled trial. Psychopharmacology (Berl) 2004; 172 (04) 400-408
    CrossrefPubMedGoogle Scholar
  • 78 Lebert F, Stekke W, Hasenbroekx C, Pasquier F. Frontotemporal dementia: a randomised, controlled trial with trazodone. Dement Geriatr Cogn Disord 2004; 17 (04) 355-359
    CrossrefPubMedGoogle Scholar
  • 79 Herrmann N, Black SE, Chow T, Cappell J, Tang-Wai DF, Lanctôt KL. Serotonergic function and treatment of behavioral and psychological symptoms of frontotemporal dementia. Am J Geriatr Psychiatry 2012; 20 (09) 789-797
    CrossrefPubMedGoogle Scholar
  • 80 Czarnecki K, Kumar N, Josephs KA. Parkinsonism and tardive antecollis in frontotemporal dementia--increased sensitivity to newer antipsychotics?. Eur J Neurol 2008; 15 (02) 199-201
    CrossrefPubMedGoogle Scholar
  • 81 Nomoto H, Matsubara Y, Ichimiya Y, Arai H. A case of frontotemporal dementia with sexual disinhibition controlled by aripiprazole. Psychogeriatrics 2017; 17 (06) 509-510
    CrossrefPubMedGoogle Scholar
  • 82 Dick KM, van Swieten JC, Gerhard A. , et al. Symptom onset in genetic frontotemporal dementia. Alzheimers Dement 2017; 13 (Suppl. 01) 1337
    CrossrefPubMedGoogle Scholar
  • 83 Tsai RM, Boxer AL. Therapy and clinical trials in frontotemporal dementia: past, present, and future. J Neurochem 2016; 138 (Suppl. 01) 211-221
    CrossrefPubMedGoogle Scholar
  • 84 Gordon E, Rohrer JD, Kim LG. , et al. Measuring disease progression in frontotemporal lobar degeneration: a clinical and MRI study. Neurology 2010; 74 (08) 666-673
    CrossrefPubMedGoogle Scholar
  • 85 Okamura N, Harada R, Ishiki A, Kikuchi A, Nakamura T, Kudo Y. The development and validation of tau PET tracers: current status and future directions. Clin Transl Imaging 2018; 6 (04) 305-316
    CrossrefPubMedGoogle Scholar
  • 86 Rohrer JD, Woollacott IO, Dick KM. , et al. Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia. Neurology 2016; 87 (13) 1329-1336
    CrossrefPubMedGoogle Scholar
  • 87 Feneberg E, Steinacker P, Volk AE. , et al. Progranulin as a candidate biomarker for therapeutic trial in patients with ALS and FTLD. J Neural Transm (Vienna) 2016; 123 (03) 289-296
    CrossrefPubMedGoogle Scholar
  • 88 Borroni B, Benussi A, Premi E. , et al. Biological, neuroimaging, and neurophysiological markers in frontotemporal dementia: three faces of the same coin. J Alzheimers Dis 2018; 62 (03) 1113-1123
    CrossrefPubMedGoogle Scholar
  • 89 Foiani MS, Woollacott IO, Heller C. , et al. Plasma tau is increased in frontotemporal dementia. J Neurol Neurosurg Psychiatry 2018; 89 (08) 804-807
    CrossrefPubMedGoogle Scholar
  • 90 Woollacott IOC, Nicholas JM, Heslegrave A. , et al. Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup. Alzheimers Res Ther 2018; 10 (01) 79
    CrossrefPubMedGoogle Scholar
  • 91 Ahmed RM, Ke YD, Vucic S. , et al. Physiological changes in neurodegeneration - mechanistic insights and clinical utility. Nat Rev Neurol 2018; 14 (05) 259-271
    CrossrefPubMedGoogle Scholar
  • 92 Kim WS, Jary E, Pickford R. , et al. Lipidomics analysis of behavioral variant frontotemporal dementia: a scope for biomarker development. Front Neurol 2018; 9: 104
    CrossrefPubMedGoogle Scholar
  • 93 Marshall CR, Hardy CJD, Allen M. , et al. Cardiac responses to viewing facial emotion differentiate frontotemporal dementias. Ann Clin Transl Neurol 2018; 5 (06) 687-696
    CrossrefPubMedGoogle Scholar
  • 94 Hu WT, McMillan C, Libon D. , et al. Multimodal predictors for Alzheimer disease in nonfluent primary progressive aphasia. Neurology 2010; 75 (07) 595-602
    CrossrefPubMedGoogle Scholar
  • 95 Almeida S, Gao F, Coppola G, Gao FB. Suberoylanilide hydroxamic acid increases progranulin production in iPSC-derived cortical neurons of frontotemporal dementia patients. Neurobiol Aging 2016; 42: 35-40
    CrossrefPubMedGoogle Scholar
  • 96 Capell A, Liebscher S, Fellerer K. , et al. Rescue of progranulin deficiency associated with frontotemporal lobar degeneration by alkalizing reagents and inhibition of vacuolar ATPase. J Neurosci 2011; 31 (05) 1885-1894
    CrossrefPubMedGoogle Scholar
  • 97 Ahmed RM, Irish M, van Eersel J. , et al. Mouse models of frontotemporal dementia: a comparison of phenotypes with clinical symptomatology. Neurosci Biobehav Rev 2017; 74 (Pt A): 126-138
    CrossrefPubMedGoogle Scholar
  • 98 Wild EJ, Tabrizi SJ. Therapies targeting DNA and RNA in Huntington's disease. Lancet Neurol 2017; 16 (10) 837-847
    CrossrefPubMedGoogle Scholar
  • 99 Hardy CJD, Marshall CR, Bond RL. , et al. Retained capacity for perceptual learning of degraded speech in primary progressive aphasia and Alzheimer's disease. Alzheimers Res Ther 2018; 10 (01) 70
    CrossrefPubMedGoogle Scholar
  • 100 Finger E, Berry S, Cummings J. , et al. Adaptive crossover designs for assessment of symptomatic treatments targeting behaviour in neurodegenerative disease: a phase 2 clinical trial of intranasal oxytocin for frontotemporal dementia (FOXY). Alzheimers Res Ther 2018; 10 (01) 102
    CrossrefPubMedGoogle Scholar
  • 101 Carthery-Goulart MT, da Silveira ADC, Machado TH. , et al. Nonpharmacological interventions for cognitive impairments following primary progressive aphasia: a systematic review of the literature. Dement Neuropsychol 2013; 7 (01) 122-131
    CrossrefPubMedGoogle Scholar
  • 102 Tsapkini K, Webster KT, Ficek BN. , et al. Electrical brain stimulation in different variants of primary progressive aphasia: a randomized clinical trial. Alzheimers Dement (N Y) 2018; 4: 461-472
    PubMedGoogle Scholar
  • 103 Tsakiris M, Hesse MD, Boy C, Haggard P, Fink GR. Neural signatures of body ownership: a sensory network for bodily self-consciousness. Cereb Cortex 2007; 17 (10) 2235-2244
    CrossrefPubMedGoogle Scholar
  • 104 Downey LE, Fletcher PD, Golden HL. , et al. Altered body schema processing in frontotemporal dementia with C9ORF72 mutations. J Neurol Neurosurg Psychiatry 2014; 85 (09) 1016-1023
    CrossrefPubMedGoogle Scholar
  • 105 Guo CC, Sturm VE, Zhou J. , et al. Dominant hemisphere lateralization of cortical parasympathetic control as revealed by frontotemporal dementia. Proc Natl Acad Sci U S A 2016; 113 (17) E2430-E2439
    CrossrefPubMedGoogle Scholar